Find Clarity in Your Lung Health Journey
When facing lung health concerns, uncertainty can feel overwhelming. Our Lung Cancer Targeted Gene Panel with PDL-1 (DAKO) Test provides the answers you need to make informed decisions about your treatment and future. This comprehensive genetic analysis helps identify the specific drivers of lung cancer growth, opening doors to personalised treatment options that target your cancer’s unique characteristics.
Understanding Your Lung Cancer Genetic Profile
This advanced test examines multiple genetic markers that play crucial roles in lung cancer development and progression. Using cutting-edge Next Generation Sequencing (NGS), Fluorescence In Situ Hybridisation (FISH), and Immunohistochemistry (IHC) technologies, we analyse:
- ALK1 & ROS1: Fusion genes that can be targeted with specific medications
- MET amplification & mutations: Important for cancer growth and spread
- KRAS & BRAF: Key signalling pathways in cancer development
- ERBB2 & EGFR: Growth factor receptors that drive cancer progression
- PDL-1 (DAKO): Immune checkpoint marker that indicates potential response to immunotherapy
Who Should Consider This Test?
This test is particularly valuable if you:
- Have been diagnosed with non-small cell lung cancer
- Are experiencing persistent cough, chest pain, or breathing difficulties
- Have a family history of lung cancer
- Are a current or former smoker with concerning symptoms
- Want to explore targeted therapy options beyond traditional chemotherapy
- Need to determine if immunotherapy might be effective for your cancer
Early genetic profiling can significantly impact treatment success and quality of life.
Why Genetic Testing Matters for Your Health
Understanding your cancer’s genetic makeup transforms treatment from guesswork to precision medicine. Key benefits include:
- Personalised Treatment: Identify which targeted therapies are most likely to work for your specific cancer type
- Immunotherapy Guidance: PDL-1 testing helps determine if immune checkpoint inhibitors could be effective
- Avoid Unnecessary Treatment: Prevent side effects from treatments unlikely to work
- Better Outcomes: Targeted therapies often have higher success rates with fewer side effects
- Peace of Mind: Knowing your treatment plan is based on scientific evidence rather than trial and error
Understanding Your Test Results
Our comprehensive report provides clear, actionable information that your oncologist can use immediately. We explain:
- Which genetic mutations are present in your cancer
- How these mutations affect cancer growth and behaviour
- Which targeted therapies are FDA-approved for your specific mutations
- Clinical trial options that might be suitable
- PDL-1 expression levels and what they mean for immunotherapy
Your results come with expert interpretation, making complex genetic information accessible and useful for your treatment decisions.
Investment in Your Health
| Test Option | Regular Price | Special Price | Savings |
|---|---|---|---|
| Lung Cancer Targeted Gene Panel with PDL-1 (DAKO) | ZAR 11,700 | ZAR 3,300 |
Consider this: The cost of ineffective treatment and prolonged illness often far exceeds the investment in precise genetic testing.
Why Trust Oracle Genomics?
- Nationwide Coverage: Available across South Africa including Johannesburg, Cape Town, Durban, and Pretoria
- Expert Accuracy: Advanced NGS, FISH, and IHC technologies ensure reliable results
- Quick Turnaround: Samples received by 1st/16th of month; reports delivered 15th/30th of same month
- Medical Expertise: Results interpreted by experienced oncologists and genetic specialists
- Patient-Focused: We understand the emotional journey and provide compassionate support
Take Control of Your Lung Health Today
Every day matters when it comes to cancer treatment. Don’t let uncertainty delay your path to effective treatment.
Sample Requirements: Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. Duly filled NGS Test Requisition Form (Form 40) is mandatory.
Your journey to personalised cancer care starts with one test. Let us help you find the right path forward.
